CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis ; volume:16 ; number:1 ; day:6 ; month:9 ; year:2024 ; pages:1-15 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (6.9.2024), 1-15, 12.2024

Creator
Jurasova, Vanesa
Andel, Ross
Katonova, Alzbeta
Veverova, Katerina
Zuntychova, Terezie
Horakova, Hana
Vyhnalek, Martin
Kolarova, Tereza
Matoska, Vaclav
Blennow, Kaj
Hort, Jakub
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-024-01566-w
URN
urn:nbn:de:101:1-2411222114082.189849878974
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
18.04.2025, 1:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Jurasova, Vanesa
  • Andel, Ross
  • Katonova, Alzbeta
  • Veverova, Katerina
  • Zuntychova, Terezie
  • Horakova, Hana
  • Vyhnalek, Martin
  • Kolarova, Tereza
  • Matoska, Vaclav
  • Blennow, Kaj
  • Hort, Jakub
  • SpringerLink (Online service)

Other Objects (12)

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration

Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF

Related objects